Quanterix (QTRX) - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US74766Q1013

Protein Detection Platforms, Immunoassay Instruments, Assays, Reagents

Quanterix Corporation is a life sciences company that specializes in developing and marketing cutting-edge digital immunoassay platforms. These platforms are designed to advance precision health for life sciences research and diagnostics across various regions, including North America, Europe, the Middle East, Africa, and the Asia Pacific.

The company's product portfolio includes the HD-X instrument, a protein detection platform that enables researchers to detect and analyze proteins with high precision. The SR-X instrument is another key product that allows researchers to apply Simoa detection in a broader range of applications. Additionally, the SP-X instrument, based on Simoa planar array technology, is used for measuring multiplex chemiluminescent immunoassays.

Quanterix offers a comprehensive range of assays that include all necessary components for running enzyme-based immunoassays, such as beads, capture and detector reagents, and enzyme reagents and substrate. The company also provides replacement parts, reagents, and antibodies to support researchers in their work.

Beyond its product offerings, Quanterix provides contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. These services cater to researchers working in various therapeutic areas, including neurology, oncology, cardiology, infectious diseases, and inflammation.

Quanterix primarily sells its products to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies. The company's sales strategy involves a direct field sales approach, supported by organizations and distributors or sales agents.

Founded in 2007 as Digital Genomics, Inc., the company changed its name to Quanterix Corporation in August 2007. Headquartered in Billerica, Massachusetts, Quanterix Corporation continues to innovate and advance the field of life sciences research and diagnostics.

For more information, visit Quanterix Corporation's website at https://www.quanterix.com.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Quanterix (QTRX) - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for Quanterix (QTRX) - Stock Price & Dividends

QTRX Stock Overview

Market Cap in USD 510m
Sector Healthcare
Industry Medical Devices
GiC SubIndustry Life Sciences Tools & Services
TER 0.00%
IPO / Inception 2017-12-07

QTRX Stock Ratings

Growth 5y -39.6
Fundamental -54.6
Dividend -
Rel. Performance vs Sector -5.63
Analysts 4.20/5
Fair Price Momentum 10.85 USD
Fair Price DCF -

QTRX Dividends

Yield 12m 0.00%
Yield on Cost 5y 0.00%
Dividends CAGR 5y 0.00%
Payout Consistency 0.0%

QTRX Growth Ratios

Growth 12m -40.98%
Growth Correlation 12m -24%
Growth Correlation 3m -47%
CAGR 5y -17.14%
CAGR/Mean DD 5y -0.33
Sharpe Ratio 12m -0.75
Alpha vs SP500 12m -83.27
Beta vs SP500 5y weekly 1.89
ValueRay RSI 10.72
Volatility GJR Garch 1y 59.89%
Price / SMA 50 -21.23%
Price / SMA 200 -40.8%
Current Volume 1089.2k
Average Volume 20d 469.2k

External Links for QTRX Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of QTRX stocks?
As of June 15, 2024, the stock is trading at USD 13.32 with a total of 1,089,156 shares traded.
Over the past week, the price has changed by -21.65%, over one month by -20.81%, over three months by -49.51% and over the past year by -41.37%.
What are the forecast for QTRX stock price target?
According to ValueRays Forecast Model, QTRX Quanterix will be worth about 12.6 in June 2025. The stock is currently trading at 13.32. This means that the stock has a potential downside of -5.18%.
Issuer Forecast Upside
Wallstreet Target Price 25.3 90.2
Analysts Target Price 30 125
ValueRay Target Price 12.6 -5.18